SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-034637
Filing Date
2019-09-13
Accepted
2019-09-13 07:22:56
Documents
13
Period of Report
2019-09-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 91319 alks-8k_20190910.htm   iXBRL 8-K 44465
2 EX-99.1 alks-ex991_24.htm EX-99.1 21941
  Complete submission text file 0001564590-19-034637.txt   205855

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alks-20190910.xsd EX-101.SCH 6201
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20190910_lab.xml EX-101.LAB 19750
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20190910_pre.xml EX-101.PRE 12180
10 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20190910_htm.xml XML 3531
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 191091538
SIC: 2834 Pharmaceutical Preparations